ATRC
AtriCure, Inc.
Price Chart
Latest Quote
$27.98
+0.00 (+0.00%)
Current Price
| Previous Close | $27.98 |
| Open | $28.03 |
| Day High | $28.85 |
| Day Low | $27.59 |
| Volume | 675,617 |
Stock Information
| Shares Outstanding | 50.64M |
| Total Debt | $74.91M |
| Cash Equivalents | $146.16M |
| Revenue | $552.16M |
| Net Income | $-4.59M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $1.42B |
| EPS (TTM) | $-0.10 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.35B |
| Sales | $552.16M |
| Income | $-4.59M |
| Book/sh | $9.71 |
| Cash/sh | $2.89 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 2.97 |
| Current Ratio | 4.29 |
| Debt/Eq | 15.24 |
Returns & Margins
| ROA | -0.30% |
| ROE | -0.97% |
| Gross Margin | 75.61% |
| Operating Margin | 0.37% |
| Profit Margin | -0.83% |
Ownership
| Insider Ownership | 3.85% |
| Institutional Ownership | 102.39% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 80.24 |
| PEG | 10.00 |
| P/S | 2.57 |
| P/B | 2.88 |
Analyst Data
| Recommendation | none |
| Target Price | $47.00 |
Technical Indicators
| SMA20 | $27.74 |
| SMA50 | $28.04 |
| SMA200 | $33.52 |
| RSI | 53.63 |
| ATR | 1.2293 |
| Shares Float | 48.55M |
| Short Float | 6.99% |
| Short Ratio | 3.70 |
| Volatility | 1.26 |
| Rel Volume | 0.90 |
Performance History
| Week | +2.49% |
| Month | -0.50% |
| Quarter | -5.41% |
| 6 Months | -33.98% |
| YTD | -28.75% |
| Year | -11.51% |
| 3 Years | -40.66% |
| 5 Years | -62.17% |
| 10 Years | +89.18% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-16 | $27.98 | 702,600 |
| 2026-06-15 | $27.98 | 808,500 |
| 2026-06-12 | $28.79 | 700,900 |
| 2026-06-11 | $28.41 | 1,105,100 |
| 2026-06-10 | $27.51 | 703,900 |
| 2026-06-09 | $27.30 | 607,200 |
| 2026-06-08 | $26.92 | 559,500 |
| 2026-06-05 | $27.10 | 523,500 |
| 2026-06-04 | $27.27 | 839,400 |
| 2026-06-03 | $26.20 | 592,200 |
| 2026-06-02 | $25.86 | 672,100 |
| 2026-06-01 | $26.48 | 811,100 |
| 2026-05-29 | $27.67 | 722,200 |
| 2026-05-28 | $28.09 | 1,122,700 |
| 2026-05-27 | $27.45 | 1,046,500 |
| 2026-05-26 | $28.81 | 1,120,700 |
| 2026-05-22 | $28.29 | 499,200 |
| 2026-05-21 | $28.82 | 1,042,400 |
| 2026-05-20 | $29.00 | 679,300 |
| 2026-05-19 | $28.80 | 714,900 |
| 2026-05-18 | $28.48 | 732,800 |
About AtriCure, Inc.
AtriCure, Inc. engages in the development, manufacture, and sale of devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, the Asia-Pacific, and internationally. It offers Isolator Synergy Ablation System clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, a single-use disposable RF products for the treatment of cardiac arrhythmias; cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; and EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation. It also provides cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; cryoXT probes, a cryoablation device designed specifically for Cryo Nerve Block therapy; LARIAT System, a solution for soft-tissue closure; Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; and Subtle Cannula's to support access for EPi-Sense catheters. In addition, the company sells various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
đ° Latest News
Do Options Traders Know Something About AtriCure Stock We Don't?
Zacks âĸ 2026-06-11T13:43:00Z
A Look At AtriCure (ATRC) Valuation As BoxX NoAF Trial Acceleration Draws Investor Attention
Simply Wall St. âĸ 2026-06-07T04:21:43Z
AtriCure (ATRC) Advances Key Heart Disease Trial 12 Months Ahead of Schedule
Insider Monkey âĸ 2026-06-04T21:45:56Z
Boston Scientific Is the Worst Performing S&P 500 Stock. Hereâs Why.
Barrons.com âĸ 2026-05-27T20:48:00Z
AtriCure Conference: New Devices, EnCompass Drive 2026 Growth Outlook
MarketBeat âĸ 2026-05-12T19:10:19Z
Assessing AtriCure (ATRC) Valuation After A Prolonged Share Price Decline
Simply Wall St. âĸ 2026-05-11T03:15:17Z
AtriCure (ATRC) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-06T14:30:28Z
AtriCure, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-06T12:30:00Z
Here's What Key Metrics Tell Us About AtriCure (ATRC) Q1 Earnings
Zacks âĸ 2026-05-06T00:30:02Z
AtriCure Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-05T22:23:15Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $133,749,000 | $117,783,000 | $98,875,000 | $84,439,000 |
| Cost Of Revenue | $133,749,000 | $117,783,000 | $98,875,000 | $84,439,000 |
| Total Revenue | $534,528,000 | $465,307,000 | $399,245,000 | $330,379,000 |
| Operating Revenue | $534,528,000 | $465,307,000 | $399,245,000 | $330,379,000 |
| Expenses | ||||
| Interest Expense | $5,878,000 | $6,407,000 | $6,925,000 | $4,986,000 |
| Total Expenses | $543,975,000 | $505,320,000 | $425,928,000 | $373,048,000 |
| Other Income Expense | $683,000 | $-1,688,000 | $-31,000 | $-537,000 |
| Other Non Operating Income Expenses | $683,000 | $-326,000 | $-31,000 | $-537,000 |
| Interest Expense Non Operating | $5,878,000 | $6,407,000 | $6,925,000 | $4,986,000 |
| Operating Expense | $410,226,000 | $387,537,000 | $327,053,000 | $288,609,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-11,448,000 | $-44,698,000 | $-30,438,000 | $-46,466,000 |
| Net Interest Income | $-1,399,000 | $-1,973,000 | $-3,133,000 | $-2,992,000 |
| Interest Income | $4,479,000 | $4,434,000 | $3,792,000 | $1,994,000 |
| Normalized Income | $-11,448,000 | $-43,622,020 | $-30,438,000 | $-46,466,000 |
| Net Income From Continuing And Discontinued Operation | $-11,448,000 | $-44,698,000 | $-30,438,000 | $-46,466,000 |
| Total Operating Income As Reported | $-9,447,000 | $-40,013,000 | $-26,683,000 | $-42,669,000 |
| Net Income Common Stockholders | $-11,448,000 | $-44,698,000 | $-30,438,000 | $-46,466,000 |
| Net Income | $-11,448,000 | $-44,698,000 | $-30,438,000 | $-46,466,000 |
| Net Income Including Noncontrolling Interests | $-11,448,000 | $-44,698,000 | $-30,438,000 | $-46,466,000 |
| Net Income Continuous Operations | $-11,448,000 | $-44,698,000 | $-30,438,000 | $-46,466,000 |
| Pretax Income | $-10,163,000 | $-43,674,000 | $-29,847,000 | $-46,198,000 |
| Special Income Charges | $0 | $-1,362,000 | $0 | $0 |
| Interest Income Non Operating | $4,479,000 | $4,434,000 | $3,792,000 | $1,994,000 |
| Operating Income | $-9,447,000 | $-40,013,000 | $-26,683,000 | $-42,669,000 |
| Gross Profit | $400,779,000 | $347,524,000 | $300,370,000 | $245,940,000 |
| Per Share | ||||
| Diluted EPS | $-0.24 | $-0.95 | $-0.66 | $-1.02 |
| Basic EPS | $-0.24 | $-0.95 | $-0.66 | $-1.02 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-286,020 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $16,246,000 | $-17,172,000 | $-8,109,000 | $-29,502,000 |
| Total Unusual Items | $0 | $-1,362,000 | $0 | $0 |
| Total Unusual Items Excluding Goodwill | $0 | $-1,362,000 | $0 | $0 |
| Reconciled Depreciation | $20,531,000 | $18,733,000 | $14,813,000 | $11,710,000 |
| EBITDA (Bullshit earnings) | $16,246,000 | $-18,534,000 | $-8,109,000 | $-29,502,000 |
| EBIT | $-4,285,000 | $-37,267,000 | $-22,922,000 | $-41,212,000 |
| Diluted Average Shares | $47,750,000 | $46,965,000 | $46,309,000 | $45,740,000 |
| Basic Average Shares | $47,750,000 | $46,965,000 | $46,309,000 | $45,740,000 |
| Diluted NI Availto Com Stockholders | $-11,448,000 | $-44,698,000 | $-30,438,000 | $-46,466,000 |
| Tax Provision | $1,285,000 | $1,024,000 | $591,000 | $268,000 |
| Research And Development | $99,209,000 | $96,178,000 | $73,915,000 | $57,337,000 |
| Selling General And Administration | $311,017,000 | $291,359,000 | $253,138,000 | $231,272,000 |
| Other Special Charges | - | $1,362,000 | - | - |
| Impairment Of Capital Assets | - | - | $0 | $0 |
| Restructuring And Mergern Acquisition | - | - | $0 | $0 |
Fetched: 2026-06-12
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $209,128,000 | $169,721,000 | $167,401,000 | $182,634,000 |
| Total Assets | $654,179,000 | $609,328,000 | $613,932,000 | $585,448,000 |
| Total Non Current Assets | $331,662,000 | $341,502,000 | $347,686,000 | $370,234,000 |
| Other Non Current Assets | $2,864,000 | $2,868,000 | $2,160,000 | $1,985,000 |
| Goodwill And Other Intangible Assets | $282,807,000 | $291,248,000 | $298,767,000 | $274,120,000 |
| Other Intangible Assets | $48,026,000 | $56,467,000 | $63,986,000 | $39,339,000 |
| Current Assets | $322,517,000 | $267,826,000 | $266,246,000 | $215,214,000 |
| Other Current Assets | $9,944,000 | $9,431,000 | $8,563,000 | $5,477,000 |
| Inventory | $78,492,000 | $75,335,000 | $67,897,000 | $45,931,000 |
| Receivables | $66,653,000 | $60,339,000 | $52,501,000 | $42,693,000 |
| Accounts Receivable | $66,653,000 | $60,339,000 | $52,501,000 | $42,693,000 |
| Allowance For Doubtful Accounts Receivable | $-750,000 | $-550,000 | $-500,000 | $-230,000 |
| Gross Accounts Receivable | $67,403,000 | $60,889,000 | $53,001,000 | $42,923,000 |
| Cash Cash Equivalents And Short Term Investments | $167,428,000 | $122,721,000 | $137,285,000 | $121,113,000 |
| Cash And Cash Equivalents | $167,428,000 | $122,721,000 | $84,310,000 | $58,099,000 |
| Investmentin Financial Assets | - | - | $0 | $51,509,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $73,381,000 | $73,725,000 | $74,494,000 | $74,548,000 |
| Long Term Debt And Capital Lease Obligation | $73,381,000 | $73,725,000 | $71,961,000 | $69,076,000 |
| Long Term Debt | $61,865,000 | $61,865,000 | $60,593,000 | $56,834,000 |
| Current Debt And Capital Lease Obligation | - | $2,805,000 | $2,533,000 | $5,472,000 |
| Current Debt | - | $2,805,000 | $2,533,000 | $5,472,000 |
| Net Debt | - | - | - | $4,207,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $162,244,000 | $148,359,000 | $147,764,000 | $128,694,000 |
| Total Non Current Liabilities Net Minority Interest | $80,724,000 | $74,935,000 | $73,195,000 | $70,302,000 |
| Other Non Current Liabilities | $7,343,000 | $1,210,000 | $1,234,000 | $1,226,000 |
| Current Liabilities | $81,520,000 | $73,424,000 | $74,569,000 | $58,392,000 |
| Other Current Liabilities | $3,121,000 | $2,805,000 | - | $5,472,000 |
| Payables And Accrued Expenses | $28,163,000 | $27,991,000 | $29,857,000 | $23,199,000 |
| Payables | $25,310,000 | $25,032,000 | $27,354,000 | $19,898,000 |
| Accounts Payable | $25,310,000 | $25,032,000 | $27,354,000 | $19,898,000 |
| Total Tax Payable | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $491,935,000 | $460,969,000 | $466,168,000 | $456,754,000 |
| Total Equity Gross Minority Interest | $491,935,000 | $460,969,000 | $466,168,000 | $456,754,000 |
| Stockholders Equity | $491,935,000 | $460,969,000 | $466,168,000 | $456,754,000 |
| Gains Losses Not Affecting Retained Earnings | $566,000 | $-1,035,000 | $-993,000 | $-4,096,000 |
| Other Equity Adjustments | $566,000 | $-1,035,000 | $-993,000 | $-4,096,000 |
| Retained Earnings | $-413,203,000 | $-401,755,000 | $-357,057,000 | $-326,619,000 |
| Other | ||||
| Ordinary Shares Number | $49,792,000 | $48,869,000 | $47,526,000 | $46,563,000 |
| Share Issued | $49,792,000 | $48,869,000 | $47,526,000 | $46,563,000 |
| Tangible Book Value | $209,128,000 | $169,721,000 | $167,401,000 | $182,634,000 |
| Invested Capital | $553,800,000 | $522,834,000 | $529,294,000 | $519,060,000 |
| Working Capital | $240,997,000 | $194,402,000 | $191,677,000 | $156,822,000 |
| Capital Lease Obligations | $11,516,000 | $11,860,000 | $11,368,000 | $12,242,000 |
| Total Capitalization | $553,800,000 | $522,834,000 | $526,761,000 | $513,588,000 |
| Additional Paid In Capital | $904,522,000 | $863,710,000 | $824,170,000 | $787,422,000 |
| Capital Stock | $50,000 | $49,000 | $48,000 | $47,000 |
| Common Stock | $50,000 | $49,000 | $48,000 | $47,000 |
| Long Term Capital Lease Obligation | $11,516,000 | $11,860,000 | $11,368,000 | $12,242,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $46,760,000 | $39,505,000 | $39,425,000 | $26,924,000 |
| Current Provisions | $3,476,000 | $3,123,000 | $2,754,000 | $2,797,000 |
| Current Accrued Expenses | $2,853,000 | $2,959,000 | $2,503,000 | $3,301,000 |
| Goodwill | $234,781,000 | $234,781,000 | $234,781,000 | $234,781,000 |
| Accumulated Depreciation | $-69,766,000 | $-61,295,000 | $-52,424,000 | $-46,818,000 |
| Gross PPE | $115,757,000 | $108,681,000 | $99,183,000 | $89,438,000 |
| Construction In Progress | $5,042,000 | $4,331,000 | $7,332,000 | $3,909,000 |
| Other Properties | $34,264,000 | $31,414,000 | $27,731,000 | $25,141,000 |
| Machinery Furniture Equipment | $46,278,000 | $42,621,000 | $33,921,000 | $30,435,000 |
| Buildings And Improvements | $28,915,000 | $29,309,000 | $29,193,000 | $28,947,000 |
| Land And Improvements | $1,258,000 | $1,006,000 | $1,006,000 | $1,006,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $35,681,000 | $34,028,000 | $27,564,000 | $23,092,000 |
| Work In Process | $3,759,000 | $3,604,000 | $3,582,000 | $2,959,000 |
| Raw Materials | $39,052,000 | $37,703,000 | $36,751,000 | $19,880,000 |
| Other Short Term Investments | - | $0 | $52,975,000 | $63,014,000 |
| Investments And Advances | - | - | $0 | $51,509,000 |
| Available For Sale Securities | - | - | - | $51,509,000 |
| Current Capital Lease Obligation | - | - | - | - |
| Leases | - | - | - | - |
Fetched: 2026-06-12
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $42,284,000 | $-11,255,000 | $-37,514,000 | $-39,022,000 |
| Operating Activities | ||||
| Operating Cash Flow | $57,334,000 | $12,204,000 | $4,484,000 | $-22,141,000 |
| Cash Flow From Continuing Operating Activities | $57,334,000 | $12,204,000 | $4,484,000 | $-22,141,000 |
| Operating Gains Losses | - | $1,362,000 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-15,050,000 | $-23,459,000 | $-41,998,000 | $-16,881,000 |
| Investing Cash Flow | $-14,550,000 | $30,234,000 | $21,817,000 | $44,006,000 |
| Cash Flow From Continuing Investing Activities | $-14,550,000 | $30,234,000 | $21,817,000 | $44,006,000 |
| Net Other Investing Changes | $500,000 | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-11,163,000 | $-6,951,000 | $-6,557,000 | $-12,201,000 |
| Financing Cash Flow | $1,176,000 | $-3,603,000 | $-32,000 | $-7,059,000 |
| Cash Flow From Continuing Financing Activities | $1,176,000 | $-3,603,000 | $-32,000 | $-7,059,000 |
| Net Other Financing Charges | $6,250,000 | - | $-60,000 | - |
| Cash Dividends Paid | $0 | $0 | $0 | $0 |
| Net Common Stock Issuance | $-11,163,000 | $-6,951,000 | $-6,557,000 | $-12,201,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-1,201,000 | $-62,879,000 | $-992,000 | $-899,000 |
| Issuance Of Debt | $0 | $61,210,000 | $0 | $0 |
| Interest Paid Supplemental Data | $5,255,000 | $5,951,000 | $6,376,000 | $4,270,000 |
| Income Tax Paid Supplemental Data | $1,290,000 | $619,000 | $395,000 | $192,000 |
| End Cash Position | $167,428,000 | $122,721,000 | $84,310,000 | $58,099,000 |
| Beginning Cash Position | $122,721,000 | $84,310,000 | $58,099,000 | $43,654,000 |
| Effect Of Exchange Rate Changes | $747,000 | $-424,000 | $-58,000 | $-361,000 |
| Changes In Cash | $43,960,000 | $38,835,000 | $26,269,000 | $14,806,000 |
| Interest Paid Cff | $0 | $-1,069,000 | $-60,000 | $0 |
| Proceeds From Stock Option Exercised | $7,290,000 | $6,086,000 | $7,577,000 | $6,041,000 |
| Common Stock Payments | $-11,163,000 | $-6,951,000 | $-6,557,000 | $-12,201,000 |
| Net Issuance Payments Of Debt | $-1,201,000 | $-1,669,000 | $-992,000 | $-899,000 |
| Net Long Term Debt Issuance | $-1,201,000 | $-1,669,000 | $-992,000 | $-899,000 |
| Long Term Debt Payments | $-1,201,000 | $-62,879,000 | $-992,000 | $-899,000 |
| Long Term Debt Issuance | $0 | $61,210,000 | $0 | $0 |
| Net Investment Purchase And Sale | $0 | $53,668,000 | $63,815,000 | $60,887,000 |
| Sale Of Investment | $0 | $53,668,000 | $63,815,000 | $85,524,000 |
| Net Intangibles Purchase And Sale | $-6,000,000 | $-12,000,000 | $-30,000,000 | $0 |
| Purchase Of Intangibles | $-6,000,000 | $-12,000,000 | $-30,000,000 | $0 |
| Net PPE Purchase And Sale | $-9,050,000 | $-11,434,000 | $-11,998,000 | $-16,881,000 |
| Sale Of PPE | $0 | $25,000 | $0 | $0 |
| Purchase Of PPE | $-9,050,000 | $-11,459,000 | $-11,998,000 | $-16,881,000 |
| Change In Working Capital | $-4,286,000 | $-18,358,000 | $-18,240,000 | $-18,880,000 |
| Change In Other Working Capital | $-2,129,000 | $-1,036,000 | $-1,193,000 | $-1,782,000 |
| Change In Other Current Assets | $-328,000 | $-949,000 | $-3,084,000 | $-515,000 |
| Change In Payables And Accrued Expense | $6,037,000 | $-332,000 | $17,739,000 | $-289,000 |
| Change In Accrued Expense | $6,997,000 | $1,199,000 | $11,562,000 | $-2,966,000 |
| Change In Payable | $-960,000 | $-1,531,000 | $6,177,000 | $2,677,000 |
| Change In Account Payable | $-960,000 | $-1,531,000 | $6,177,000 | $2,677,000 |
| Change In Inventory | $-2,256,000 | $-7,740,000 | $-21,830,000 | $-7,305,000 |
| Change In Receivables | $-5,610,000 | $-8,301,000 | $-9,872,000 | $-8,989,000 |
| Changes In Account Receivables | $-5,610,000 | $-8,301,000 | $-9,872,000 | $-8,989,000 |
| Other Non Cash Items | $7,852,000 | $14,653,000 | $1,989,000 | $1,246,000 |
| Stock Based Compensation | $44,685,000 | $40,405,000 | $35,728,000 | $28,771,000 |
| Amortization Of Securities | $0 | $107,000 | $632,000 | $1,478,000 |
| Depreciation Amortization Depletion | $20,531,000 | $18,733,000 | $14,813,000 | $11,710,000 |
| Depreciation And Amortization | $20,531,000 | $18,733,000 | $14,813,000 | $11,710,000 |
| Amortization Cash Flow | $8,441,000 | $7,519,000 | $5,353,000 | $3,653,000 |
| Amortization Of Intangibles | $8,441,000 | $7,519,000 | $5,353,000 | $3,653,000 |
| Depreciation | $12,090,000 | $11,214,000 | $9,460,000 | $8,057,000 |
| Net Income From Continuing Operations | $-11,448,000 | $-44,698,000 | $-30,438,000 | $-46,466,000 |
| Purchase Of Investment | - | $0 | $0 | $-24,637,000 |
| Asset Impairment Charge | - | - | $0 | $0 |
| Net Business Purchase And Sale | - | - | - | - |
| Purchase Of Business | - | - | - | - |
Fetched: 2026-06-12